Why Does Hematocrit Rise During Testosterone Therapy?
The short, direct answer: testosterone stimulates erythropoietin and acts directly on the bone marrow, increasing red blood cell production — more strongly with injections than with gels. We cover the full mechanism and how this risk is managed in a separate, in-depth entry.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — this is an interpretive question, not an intervention.
Who it's for
Table of contents
TL;DR
The short, direct answer: testosterone stimulates erythropoietin and acts directly on the bone marrow, increasing red blood cell production — more strongly with injections than with gels. We cover the full mechanism and how this risk is managed in a separate, in-depth entry.
- →Gives a quick, unambiguous answer to this specific question without needing to read a longer piece
- →Helps understand that this is a predictable pharmacological effect, not a therapy error
- →Points directly to where to find the full mechanism and specific risk-management strategies
| Type of question | A short mechanism explanation, without numerical thresholds |
|---|---|
| Level of evidence | Strong — the mechanism is confirmed in clinical and observational studies |
| Who it applies to | Any man starting or continuing TRT |
| Key mechanism | Erythropoietin + direct bone marrow action + a drop in hepcidin |
| What to do next | Full mechanism and risk management — see our entry "TRT and Hematocrit" |
Understand
Overview
In short: testosterone raises hematocrit because it stimulates erythropoietin (EPO) production in the kidneys and acts directly on the bone marrow stem cells responsible for making red blood cells. It also lowers hepcidin — a hormone that regulates iron availability — which eases the production of new hemoglobin once the marrow is already stimulated to work harder. These are three overlapping mechanisms, not a random reaction of the body.
The effect clearly depends on the delivery form. Intramuscular or subcutaneous injections, especially short-acting esters given infrequently in large doses, produce high peak testosterone concentrations right after administration — and it's that peak concentration, more than the average dose, that drives erythropoiesis stimulation. Transdermal gels and patches give a much more stable, flat daily concentration profile without pronounced peaks, which explains why they carry a markedly lower risk of a hematocrit rise than injections.
This entry is intentionally short — it's a direct answer to exactly this question. The full mechanism (the role of erythropoietin, hepcidin, and androgen receptors in the marrow), detailed data on how often this happens, and how this risk is actually managed in clinical practice (dose reduction, delivery form change, phlebotomy) are covered at length in our separate entry "TRT and Hematocrit" — that's also where you'll find the full list of source studies.
Mechanism of action
The mechanism in short: a rise in blood testosterone stimulates erythropoietin secretion by the kidneys (partly via the HIF pathway), while also acting directly on androgen receptors present on erythroid progenitor cells in the bone marrow, increasing their sensitivity to EPO and speeding their maturation into red blood cells — regardless of whether peripheral EPO concentration has actually risen.
At the same time, testosterone lowers hepatic hepcidin, increasing the iron available for producing new hemoglobin. The sum of these three overlapping pathways explains why a rise in hematocrit is one of the best and most consistently documented side effects of testosterone therapy. A full description of each of these mechanisms, with numerical data on frequency and effect size, is available in our entry "TRT and Hematocrit."
Erythropoietin stimulation
Testosterone increases EPO secretion by the kidneys, triggering new red cell production in the bone marrow.
Direct bone marrow action
Androgen receptors on progenitor cells speed their maturation into red blood cells, independent of blood EPO levels.
A stronger effect with high-peak forms
Injections with high peak concentrations stimulate erythropoiesis more strongly than stable transdermal forms.
Evidence: strong — based on 1 study in this database.
Benefits
Common myths
MythA rise in hematocrit on TRT is a sign of a dosing error.
FactIt's a predictable, pharmacological effect of testosterone on erythropoietin and bone marrow, present in a significant share of treated men — not a sign of error.
MythThe delivery form doesn't matter, only the dose counts.
FactPeak concentrations, more than the dose itself, drive erythropoiesis — which is why injections carry higher risk than stable transdermal forms.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Testosterone stimulates erythropoietin in the kidneys, acts directly on the bone marrow, and lowers hepcidin, which together increase red blood cell production. The effect is stronger with injectable forms with high peak concentrations than with gels or patches.
Yes, it's one of the best-documented and most predictable effects of testosterone therapy, not a sign of a treatment error.
A detailed description of the role of erythropoietin, hepcidin, and bone marrow androgen receptors, along with data on frequency and risk-management strategies, is in our in-depth entry "TRT and Hematocrit."
What to combine with
Good combinations
TRT and Hematocrit — Why Does Testosterone Raise It? — The full mechanism, data on how often this occurs, and risk-management strategies — this entry is just a short, direct answer.
Hematocrit During TRT — What's a Safe Value, and What to Do If It's Elevated? — Specific numerical hematocrit thresholds and an action plan for an elevated result.
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Delivery form — injections with high peak concentrations raise hematocrit more strongly than transdermal gels and patches
Smoking and high altitude — act additively with testosterone's effect on erythropoiesis
Iron supplementation without an indication — with hepcidin already lowered by testosterone, it can further ease red cell production
Is it worth taking?
Who it's for
- Men looking for a quick, specific answer to why hematocrit rises on TRT
- People who want to move on afterward to a fuller explanation of the mechanism and risk management
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
Testosterone raises hematocrit through three overlapping pathways: erythropoietin, direct bone marrow action, and a drop in hepcidin.
Injections with high peak concentrations raise hematocrit more strongly than gels and patches.
Studies
Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point
Strong evidenceBachman E et al. · The Journals of Gerontology: Series A · 2014
A study showing that the rise in hemoglobin and hematocrit under testosterone is linked to increased erythropoietin and decreased ferritin and hepcidin as early as 1–3 months into therapy, pointing to a new, higher equilibrium set point for erythropoiesis established under the androgen.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Piotr ZielińskiEndocrinologist
Piotr has practiced endocrinology for more than fifteen years, mostly in male hormonal disorders and metabolic health. He joined VitMode as a scientific consultant because, as he jokes, he got tired of explaining the same testosterone questions at every appointment and decided to write the answers down properly, once. He reviews content on hormone therapy, supplement pharmacology and drug interactions, making sure articles never turn into encouragement to self-supplement in situations that genuinely need diagnostics and medical supervision. His professional motto — "evidence first, enthusiasm second" — has come up more than once with a patient who arrived with a supplement plan they found online.
235 publications on this site
Medical review
dr Katarzyna LewandowskaCardiologist
Katarzyna works as a cardiologist at a Warsaw teaching hospital and has spent years focused on cardiovascular prevention — trying, as she puts it, to convince people to change their habits before they end up on her ward, not after. She joined VitMode after a series of conversations with Anna at a lifestyle-medicine conference, where the two discovered they shared the same frustration: an internet full of contradictory claims about cholesterol, aspirin and heart supplements, with no clear signal of what's actually backed by research. She reviews content on cardiovascular health, lipid panels and pharmacological prevention, consistently distinguishing what helps a statistical population from what makes sense for a specific person. Off duty, she road-cycles — not for performance, but because, in her words, it's hard to write credibly about prevention without practicing it yourself.
35 publications on this site
Related entries
4.6TRT and Hematocrit — Why Does Testosterone Raise It?
A rise in hematocrit is the best-documented side effect of testosterone therapy — it affects as many as one in four men on injections. We walk through the mechanism step by step, explain why the delivery method matters, and look at how this risk is actually managed in clinical practice.
4.7Hematocrit During TRT — What's a Safe Value, and What to Do If It's Elevated?
50%, 52%, 54%, 56% — each of those numbers on a TRT blood panel means something different. A concrete guide to hematocrit thresholds per the Endocrine Society and AUA guidelines: when more frequent monitoring is enough, when to reduce the dose, when to consider phlebotomy, and when to pause therapy.
4.6Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
4.6Does a High Hematocrit on TRT Always Mean a Problem?
A single elevated hematocrit reading on a blood count doesn't necessarily mean a real problem — dehydration at the draw, altitude, or the timing of the draw relative to an injection can all inflate the number without any actual change in the body. We explain when a single result can be ignored, and when it genuinely deserves attention.
4.7How Often to Test Testosterone on TRT? Monitoring Schedule and Checkups
Starting testosterone therapy isn't the end of diagnostics — it's the start of a new, recurring rhythm of checkups. We explain which tests happen at month 3, which at year one, and which need repeating for as long as therapy continues — and how the schedule differs between injectable and gel forms.
4.7TRT — Side Effects and Therapy Monitoring
Erythrocytosis, fertility impact, PSA screening, and the cardiovascular risk question — what testosterone replacement therapy safety actually involves and how it's monitored.
4.7TRT (Testosterone Replacement Therapy) — What Is It and Who Is It For?
TRT isn't a supplement for fatigue — it's pharmacological treatment for a confirmed testosterone deficiency, with a real but limited list of benefits and an equally real list of people who simply don't qualify for it.
Related articles
PoradnikiTRT or Lifestyle Change? What Actually Raises Testosterone Before You Consider Therapy
Before considering testosterone replacement therapy, it's worth checking how much sleep, training, and fat loss can realistically achieve — and when these interventions genuinely aren't enough.
July 29, 2026
PoradnikiLow Testosterone: 12 Symptoms Men Often Don't Connect to Their Hormones
Fatigue, a flatter mood, trouble building fitness despite training — most men blame these on age, stress, or a lack of willpower. We look at which symptoms are actually worth linking to low testosterone, and why none of them, on its own, proves anything.
August 15, 2026
PoradnikiHow to Raise Testosterone Naturally? What Actually Works vs. What's Marketing
The 'testosterone booster' market is worth billions, and most of it does nothing for a man with a normal hormone level. We check what real clinical trials say — from sleep and training to vitamin D, zinc, and ashwagandha — and separate genuine effect from marketing copy.
August 15, 2026
PoradnikiTRT and Fertility: Can Testosterone Therapy Cause Infertility?
Testosterone replacement therapy can suppress sperm production even in men with a 'perfect' blood testosterone result — we explain the mechanism, the real scale of the problem, and the concrete options for men who want to have children.
August 15, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.